Literature DB >> 15850850

Differential diagnosis and imaging in Cushing's syndrome.

John R Lindsay1, Lynnette K Nieman.   

Abstract

Establishing the cause of Cushing's syndrome (CS) is one of the most challenging processes in clinical endocrinology. Biochemical testing, including measurement of plasma adrenocorticotropin (ACTH), high-dose dexamethasone suppression, and corticotropin-releasing hormone stimulation testing, is integral to the differential diagnosis. No existing test has sufficient diagnostic accuracy when used alone, however. The adjunctive use of focused imaging, including CT, MRI, and nuclear imaging modalities, often can provide a diagnosis. In patients with ACTH-dependent CS, bilateral inferior petrosal sinus sampling can facilitate a diagnosis in those with discrepant clinical features, biochemistry, or imaging. This article focuses on current biochemical and radiologic strategies for the differential diagnosis of CS.

Entities:  

Mesh:

Year:  2005        PMID: 15850850     DOI: 10.1016/j.ecl.2005.01.009

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  23 in total

1.  Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.

Authors:  Nicola M Neary; Ariel Lopez-Chavez; Brent S Abel; Alison M Boyce; Nicholas Schaub; King Kwong; Constantine A Stratakis; Cesar A Moran; Giuseppe Giaccone; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

2.  A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing's syndrome.

Authors:  J R Lindsay; V K Shanmugam; E H Oldfield; A T Remaley; L K Nieman
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 3.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.

Authors:  Maria Güemes; Philip G Murray; Caroline E Brain; Helen A Spoudeas; Catherine J Peters; Peter C Hindmarsh; Mehul T Dattani
Journal:  Eur J Pediatr       Date:  2016-05-12       Impact factor: 3.183

5.  Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing's disease.

Authors:  Jung Soo Lim; Seung Ku Lee; Se Hoon Kim; Eun Jig Lee; Sun Ho Kim
Journal:  Endocrine       Date:  2011-06-19       Impact factor: 3.633

Review 6.  Diagnostic criteria for polycystic ovarian syndrome.

Authors:  F J Broekmans; B C J M Fauser
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 7.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

8.  Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.

Authors:  Marina S Zemskova; Bhaskar Gundabolu; Ninet Sinaii; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Iffat Chowdhury; Ahmed M Gharib; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

9.  Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life.

Authors:  Susan G Coe; Winston W Tan; Thomas P Fox
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

10.  Inferior petrosal sinus ACTH and prolactin responses to CRH in ACTH-dependent Cushing's syndrome: a single centre experience from the United Kingdom.

Authors:  Christina Daousi; Thomas Nixon; Mohsen Javadpour; Katharine Hayden; Ian A MacFarlane
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.